<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: ELAD</title>
<meta name="Author" content="Spudboy100@aol.com (Spudboy100@aol.com)">
<meta name="Subject" content="ELAD">
<meta name="Date" content="2003-03-12">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>ELAD</h1>
<!-- received="Wed Mar 12 10:34:36 2003" -->
<!-- isoreceived="20030312173436" -->
<!-- sent="Wed, 12 Mar 2003 12:34:26 EST" -->
<!-- isosent="20030312173426" -->
<!-- name="Spudboy100@aol.com" -->
<!-- email="Spudboy100@aol.com" -->
<!-- subject="ELAD" -->
<!-- id="167.1d201fe3.2ba0c9a2@aol.com" -->
<!-- charset="UTF-8" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> <a href="mailto:Spudboy100@aol.com?Subject=Re:%20ELAD"><em>Spudboy100@aol.com</em></a><br>
<strong>Date:</strong> Wed Mar 12 2003 - 10:34:26 MST
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="4219.html">Charles Hixson: "Re: iraq:  possibly wishful thinking"</a>
<ul>
<li><strong>Previous message:</strong> <a href="4217.html">Pat Fallon: "Iraq: pass the mustard [gas]"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#4218">[ date ]</a>
<a href="index.html#4218">[ thread ]</a>
<a href="subject.html#4218">[ subject ]</a>
<a href="author.html#4218">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
<a href="http://www.sciencedaily.com/releases/2003/03/030312071533.htm">http://www.sciencedaily.com/releases/2003/03/030312071533.htm</a>
<br>
<p>&lt;&lt;The new device is a closed system to which patients are tethered via a 
<br>
catheter inserted into a vein in the neck. After the blood is initially 
<br>
filtered, the remaining plasma goes through cartridges in the ELAD where the 
<br>
human hepatocytes help fulfill much of the liverâ€™s 100 or so crucial 
<br>
functions, such as energy storage and regulation, bile production, blood 
<br>
detoxification, production of clotting factors and many essential proteins. 
<br>
The filtered blood and ELAD-treated plasma are returned to the patient.
<br>
<p>Dr. Roshan Shrestha, associate professor of medicine and medical director of 
<br>
the liver transplantation program at UNC, said ELAD could provide two major 
<br>
benefits.
<br>
<p>&quot;This device could serve as a bridge to successful transplantation, helping 
<br>
to sustain patients awaiting a donor organ.&quot;
<br>
<p>It also may enable complete recovery, he added.
<br>
<p>&quot;A remarkable feature of the liver is its capacity to regenerate. If we can 
<br>
sustain acute liver failure patients early on, right from the beginning, they 
<br>
may not need transplantation and may recover without any significant liver 
<br>
problems, including chronic liver disease.&quot;&gt;&gt;
<br>
<p>&nbsp;&nbsp;&nbsp;&nbsp;
<br>
&nbsp;&nbsp;&nbsp;&nbsp;
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="4219.html">Charles Hixson: "Re: iraq:  possibly wishful thinking"</a>
<li><strong>Previous message:</strong> <a href="4217.html">Pat Fallon: "Iraq: pass the mustard [gas]"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#4218">[ date ]</a>
<a href="index.html#4218">[ thread ]</a>
<a href="subject.html#4218">[ subject ]</a>
<a href="author.html#4218">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Wed Mar 12 2003 - 10:42:20 MST
</em></small></p>
</body>
</html>
